疑难病杂志
疑難病雜誌
의난병잡지
JOURNAL OF DIFFICULT AND COMPLICATED CASES
2014年
1期
53-55
,共3页
宁涛%白铁成%刘文娜%周志翔%刘涛
寧濤%白鐵成%劉文娜%週誌翔%劉濤
저도%백철성%류문나%주지상%류도
胃癌,进展期%新辅助化疗%奥沙利铂%替吉奥
胃癌,進展期%新輔助化療%奧沙利鉑%替吉奧
위암,진전기%신보조화료%오사리박%체길오
Gastric cancer,advanced%Neoadjuvant chemotherapy%Oxaliplatin%Tegafar gimeracil oteracil potassiam
目的:观察奥沙利铂联合替吉奥( SOX方案)治疗进展期胃癌的临床疗效及不良反应。方法58例进展期胃癌患者随机分为观察组和对照组,每组各29例。观察组化疗采用SOX方案;对照组化疗采用FOLFOX4方案(奥沙利铂+氟尿嘧啶+亚叶酸钙),每个化疗周期记录2组患者的不良反应,2个周期后评价疗效。结果观察组有效率为41.38%,疾病控制率为75.86%,对照组有效率为34.48%,疾病控制率为68.96%,2组比较差异无统计学意义( P >0.05);观察组白细胞下降及恶心呕吐发生率明显低于对照组,差异有统计学意义( P <0.05)。其余不良反应,如红细胞下降、血小板下降、腹泻、外周神经症状、手足综合征、肝功能异常等相似,差异无统计学意义(P >0.05)。结论2种方案治疗进展期胃癌均具有较好的近期疗效,但SOX方案的不良反应较轻,耐受性较好,利于提高患者化疗的依从性,改善患者的生活质量。
目的:觀察奧沙利鉑聯閤替吉奧( SOX方案)治療進展期胃癌的臨床療效及不良反應。方法58例進展期胃癌患者隨機分為觀察組和對照組,每組各29例。觀察組化療採用SOX方案;對照組化療採用FOLFOX4方案(奧沙利鉑+氟尿嘧啶+亞葉痠鈣),每箇化療週期記錄2組患者的不良反應,2箇週期後評價療效。結果觀察組有效率為41.38%,疾病控製率為75.86%,對照組有效率為34.48%,疾病控製率為68.96%,2組比較差異無統計學意義( P >0.05);觀察組白細胞下降及噁心嘔吐髮生率明顯低于對照組,差異有統計學意義( P <0.05)。其餘不良反應,如紅細胞下降、血小闆下降、腹瀉、外週神經癥狀、手足綜閤徵、肝功能異常等相似,差異無統計學意義(P >0.05)。結論2種方案治療進展期胃癌均具有較好的近期療效,但SOX方案的不良反應較輕,耐受性較好,利于提高患者化療的依從性,改善患者的生活質量。
목적:관찰오사리박연합체길오( SOX방안)치료진전기위암적림상료효급불량반응。방법58례진전기위암환자수궤분위관찰조화대조조,매조각29례。관찰조화료채용SOX방안;대조조화료채용FOLFOX4방안(오사리박+불뇨밀정+아협산개),매개화료주기기록2조환자적불량반응,2개주기후평개료효。결과관찰조유효솔위41.38%,질병공제솔위75.86%,대조조유효솔위34.48%,질병공제솔위68.96%,2조비교차이무통계학의의( P >0.05);관찰조백세포하강급악심구토발생솔명현저우대조조,차이유통계학의의( P <0.05)。기여불량반응,여홍세포하강、혈소판하강、복사、외주신경증상、수족종합정、간공능이상등상사,차이무통계학의의(P >0.05)。결론2충방안치료진전기위암균구유교호적근기료효,단SOX방안적불량반응교경,내수성교호,리우제고환자화료적의종성,개선환자적생활질량。
Objective To observe the therapeutic efficacy and adverse reactions of chemotherapy of oxaliplatine com -bined with tegafur gimeracil oteracil potassium ( SOX regimen ) in the treatment of advanced gastric cancer .Methods 58 ca-ses of advanced gastric cancer patients were randomly divided into observation group and control group , 29 cases in each group.Observation group chemotherapy using SOX regimen;chemotherapy control group using the FOLFOX 4 regimen ( oxali-platin +fluorouracil +leucovorin ) , each chemotherapy cycle recording two groups of patients with adverse reactions were evaluated after two cycles.Results In observation group effective rate was 41.38%,disease control rate was 75.86%,in con-trol group the effective rate was 34.48%, disease control rate was 68.96%, the difference was not statistically significant (P >0.05);observation group leukopenia and the incidence of nausea and vomiting was significantly lower than the control group, the difference was statistically significant ( P <0.05).The remaining adverse reactions, such as red blood cells fall, thrombocytopenia, diarrhea, peripheral neurologic symptoms, hand-foot syndrome, abnormal liver function is similar to the difference was not statistically significant ( P >0.05).Conclusion Two kinds of treatment of advanced gastric cancer have better short-term effect, but the SOX regimen mild adverse reactions , better tolerated, which will help improve patient complia nce with chemotherapy , improve the patient's quality of life.